STOCK TITAN

CRWV (CRWV) insider plans Rule 144 sale as 10b5-1 trades continue

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CRWV filed a notice of proposed sale under Rule 144 for 8,335 shares of its common stock. These are founder shares acquired on 02/25/2019 and are to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $749,733.25. The filing also lists multiple recent Rule 10b5-1 sales of CRWV common stock during the past three months by various related trusts and accounts, reflecting an ongoing, pre-arranged selling program.

Positive

  • None.

Negative

  • None.

Insights

Rule 144 filing covers a small founder share sale alongside ongoing 10b5-1 sales.

The notice covers a proposed sale of 8,335 common shares in CRWV, originally acquired as founder shares on 02/25/2019. The shares are to be sold on NASDAQ through Morgan Stanley Smith Barney LLC, with an aggregate market value of $749,733.25.

The document also lists numerous recent sales of CRWV common stock executed under Rule 10b5-1 trading plans for various trusts and accounts associated with the same address in Livingston, New Jersey. Individual line items show transactions such as 102,835 shares and 25,000 shares sold on several dates in December 2025 and January–February 2026.

The person for whose account the securities are being sold represents that they do not know any undisclosed material adverse information about CRWV’s current or prospective operations. Overall, this filing documents planned and recent secondary-market sales of existing shares, rather than any new issuance by the company.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the CRWV Form 144 filing disclose about planned share sales?

The filing shows a planned sale of 8,335 CRWV common shares, originally acquired as founder shares on 02/25/2019. They are to be sold on NASDAQ through Morgan Stanley Smith Barney LLC with an aggregate market value of $749,733.25 under Rule 144.

How many CRWV shares are outstanding according to this Form 144?

The document states that 386,401,201 CRWV common shares were outstanding. This figure provides context for the relative size of the 8,335-share planned Rule 144 sale compared with the company’s total share count at the time referenced in the notice.

What prior CRWV stock sales are listed in the past three months section?

The notice lists numerous CRWV common stock sales during the prior three months by various trusts and accounts. Individual line items include sales such as 102,835 shares, 25,000 shares, and other blocks executed on multiple dates in December 2025, January 2026, and February 2026.

Who is the broker for the CRWV Rule 144 share sale?

The proposed sale of 8,335 CRWV common shares will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s listed address is 1 New York Plaza, 8th Floor, New York, NY 10004, and the shares are to be sold on the NASDAQ exchange.

What representation does the seller make about CRWV in this Form 144?

The person for whose account the CRWV shares are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, consistent with the standard Rule 144 notice language.

What type of CRWV shares are being sold under this Rule 144 notice?

The filing specifies that the 8,335 CRWV shares proposed for sale are common stock and are described as founder shares acquired from the issuer on 02/25/2019. The consideration is indicated as N/A in the payment section.